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Ulceration of carotid atherosclerotic plaques has been associated with plaque rupture, intraplaque hemorrhage,1 
larger lipid core, and decreased amounts of fibrous tissue1 and 
decreased stability.1,2 Ulceration tends to be associated with 
greater plaque thickness and plaque volume.2,3
Plaque morphology has been previously assessed with the 
use of ultrasound imaging. Previous studies have categorized 
plaque as having an irregular or smooth morphology and 
found that irregularity of plaque significantly increased the 
risk of stroke.4 Other studies, specifically focusing on ulcer-
ations, also noted the increased risk in stroke development 
with ulcerated plaques.5–7
Our group reported previously that ulcer number (≥3 ulcers 
when both left and right carotid arteries are combined) pre-
dicted stroke, transient ischemic attack (TIA), or death.7 The 
aim of the current study is to determine whether total ulcer vol-
ume (TUV) identifies high-risk patients with atherosclerosis.
Methods
Study Population
As described previously,8 participants were patients attending the 
Stroke Prevention and Atherosclerosis Center clinic at London 
Ontario, Canada, who volunteered for a carotid imaging study fund-
ed by the Heart and Stroke Foundation of Canada. They had been 
referred to the Hypertension Clinic, the Premature Atherosclerosis 
Clinic, or the Stroke Prevention Clinic. All had been monitored annu-
ally with carotid duplex ultrasound, including measurement of total 
plaque area. Patients were eligible if their total plaque area was in the 
top tertile among the patient populations (40–600 mm2), representing 
moderate-to-severe atherosclerosis. Hypertension was defined as on 
antihypertensive medication or a baseline blood pressure <140 sys-
tolic or 90 diastolic; diabetes mellitus was defined as on medication 
for diabetes mellitus; dyslipidemic was defined as on lipid-lowering 
medication. In total, 349 patients were enrolled in the study and 
consented to a protocol approved by the Western University Human 
Ethics Research board, approval number 12401E. The participants 
were followed up for ≤5 years.
Background and Purpose—Previous studies have shown the presence of ulceration in atherosclerotic plaque either by 
categorizing the plaque as complex (irregular morphology with ulcers) or smooth or by quantifying the number of ulcers 
observed in a specific region of interest. The aim of this study was to quantify carotid total ulcer volume by 3-dimensional 
ultrasound to investigate the relationship of total ulcer volume to vascular events (strokes, transient ischemic attack, 
myocardial infarction, revascularization, or death because of cardiovascular reasons).
Methods—In total, 349 at-risk subjects provided written informed consent to carotid 3-dimensional ultrasound and 
were analyzed for ulcerations. Ulcer volume was defined as a distinct discontinuity in an atherosclerotic plaque, with 
a volume ≥1.00 mm3 as measured using manual segmentation. The sum of the volumes of all ulcers seen in both 
carotids was the total ulcer volume. Participants were monitored for ≤5 years for outcomes, including cardiovascular 
events and death.
Results—Kaplan–Meier survival analysis showed that subjects with total ulcer volume ≥5 mm3 experienced a significantly 
higher risk of developing stroke, transient ischemic attack, or death (P=0.009) and of developing stroke/transient 
ischemic attack/death/myocardial infarction/revascularization (P=0.017). Lower ulcer volumes did not predict events 
nor did ulcer depth.
Conclusions—Volume of carotid ulceration on 3-dimensional ultrasound predicts cardiovascular events. In addition to 
improving risk stratification, ulceration is a potential therapeutic target.   (Stroke. 2014;45:1437-1441.)
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Medical Therapy
All the participants received standard intensive medical therapy that 
is routine in our clinic, as previously described.9 This included advice 
on smoking cessation, maintenance of a healthy weight, exercise, 
moderate alcohol consumption, blood pressure control, lipid-lower-
ing therapy, and antiplatelet therapy or anticoagulation, as appropri-
ate. There was no alteration of therapy based on ulcer volumes.
Total Plaque Area
Carotid plaque burden, a strong predictor of cardiovascular risk,10–14 
was measured as previously described10 by tracing with a cursor the 
area of every plaque seen in the internal, external, and common ca-
rotid arteries on both sides in the plane of the longitudinal view in 
which the plaque was biggest. The sum of all plaque areas was the 
total plaque area.
Ascertainment of Outcomes
At each annual visit, the participants self-reported any events that 
occurred during the previous year; these were verified in hospital 
records. Events included stroke, TIA, revascularization (stenting, by-
pass, or endarterectomy of any artery), or death. Cause of death was 
confirmed by the primary care physician.
A TIA was defined as an episode of focal neurological symp-
toms diagnosed by a stroke neurologist as being caused by cerebral 
ischemia, with symptoms persisting <24 hours and no correspond-
ing lesion seen on brain imaging. A stroke was an episode of focal 
neurological dysfunction caused by cerebral ischemia, with symp-
toms and signs persisting >24 hours, or symptoms and signs persist-
ing <24 hours, and a corresponding lesion seen on brain imaging. 
Vascular death was defined as death because of stroke, myocardial 
infarction (MI), aortic dissection, or vascular surgery/intervention. 
Revascularization was a carotid endarterectomy or stenting, coro-
nary bypass or stenting, or bypass or stenting of the aorta or a pe-
ripheral artery.
The primary outcome was a combination of stroke, TIA, or vascu-
lar death; for the survival analyses, the first event in each patient was 
used to determine event-free survival. A secondary outcome was a 
combination of stroke, TIA, vascular death, MI, or revascularization 
(carotid, coronary, or peripheral); again, the first event in each patient 
was used in survival analyses.
Ulcer Identification and Measurement of Ulcer 
Depth and Ulcer Volume
A 3-dimensional (3D) scanning system was used to generate the 3D 
ultrasound images of the left and right carotid arteries of patients re-
cruited for the study as described previously.5,10 Both carotid arter-
ies were scanned for a length of 4 cm, centered at the bifurcation. 
As previously described,5 we defined an ulcer as being a continuous 
and distinct depression into the atherosclerotic plaque with diameter 
≥1.00 mm and depth ≥1.00 mm, with a volume ≥1.00 mm3.
Ulcer depth was measured from a contour matching the endothelial 
surface on either side of the ulcer to the depth of the ulcer, at points 
along the width of the ulcer (Figure 1). Maximum ulcer depth was 
the greatest depth for the deepest ulcer in each case with ulceration.
Manual segmentation was used to measure the volume of each 
ulcer. On identification of a distinct, continuous depression in the 
plaque, the observer identified the point at which the depression be-
gan and started the initial volume measurement by tracing the contour 
of the depression in a cross-sectional slice. The contours were traced 
in magnified views at intervals of 0.1 mm between the frames until 
the depression was no longer visible in the plaque. The slices had 
a thickness of 1 mm, and the volume was computed by the sum of 
area×thickness for all slices of each ulcer traced (Figure 2). A partici-
pant was considered to have no ulcerations when there was no depres-
sion in the carotid artery plaque ≥1.00 mm3. The sum of the volumes 
of all ulcers seen in both carotids was TUV.
Reliability of Measurement of TUV
Intraobserver and interobserver reliability of repeat measurement 
of ulcer volume was computed on 50 randomized images before 
the beginning of the study using IBM SPSS version 20 software. 
Intraobserver reliability was assessed for 1 blinded observer (M.K.), 
and the interobserver reliability was determined by comparing mea-
surements made independently by 2 blinded observers (M.K. and 
T.W.). The intraclass correlation coefficient was 0.72 for the intraob-
server reliability, and the intraclass correlation coefficient for interob-
server reliability was 0.84 using average measures.
Statistical Analysis
Kaplan–Meier survival analysis with log-rank pooled over strata 
function was used to analyze differences in event-free survival time 
Figure 1. Measurement of ulcer volume and ulcer 
depth. Contours of ulcers were traced and depth 
of ulcers measured in cross-sectional views. Each 
slice had a thickness of 1 mm; ulcer volume was 
computed from the sum of the volumes of all slices 
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between participants with a TUV <5.00 versus ≥5.00 mm3. When 
multiple events occurred in a single participant, the time to the first 
event was counted in the Kaplan–Meier survival analysis.
Results
Of the 349 patients initially recruited to the study, 313 had 3D 
ultrasound scans that were technically adequate for measure-
ment of total plaque volume. Results are presented for those 
cases. Mean age was 70.05±8.77 (SD) years, 57.5% were 
men, 80% were hypertensive, and 76% had dyslipidemia. 
There were 26 patients with stenosis of 1 carotid between 
70% and 90% and 1 patient with 1 occluded carotid artery. 
Patients with carotid stenosis ≥70% did not have signifi-
cantly higher TUV (P=0.13) or total ulcer number (P=0.12) 
Previous history of the participants before enrollment in the 
study included stroke in 22.7%, TIA in 44.1%, coronary 
bypass in 10.6%, and MI in 16.1%; 21.8% had diabetes mel-
litus, 10.2% still smoked, 53.1% quit smoking, and 36.6% 
had never smoked. Carotid stenosis of 50% to 69% was pres-
ent in 29.9% of cases.
One or more carotid ulcers were present in 124 participants. 
Of those with ulceration, TUV was 1.00 to 1.99 mm3 in 46, 
2.00 to 2.99 mm3 in 34, 3.00 to 3.99 mm3 in 18, 4.00 to 4.99 
mm3 in 7, and > 5.0 mm3 in 19. Mean TUV was 3.03 (range, 
1.01–12.35) mm3. Figure 2 shows the distribution of TUV by 
number of ulcers in a given participant. Baseline variables for 
the 2 groups of patients (ulcer volume <5 versus ≥5 mm3) and 
medications being taken at baseline and at the first  follow-up 
visit are shown in Table 1. Patients with >5 mm3 of ulcer vol-
ume had a higher number of ulcers, had higher total plaque 
area, were more likely to be smokers, and were more likely 
to be taking anticoagulants; no other variable was significant.
The median duration of patient follow-up was 3.17 years 
(range, 0.07–5 years; mean, 1024 days; SD, 313 days). There 
were complete data available on ulcer volume and survival in 
313 of the 322 participants with measurement of ulcer vol-
ume. Among them, 10 had stroke, 13 had TIA, 5 had MI, 15 
had revascularization procedure, and 13 died (4 deaths were 
vascular, 3 died from cancer, and 6 died from other causes). 
Overall, there were 59 events that occurred in 49 patients.
First event included the following: 13 revascularization 
events, 11 TIA, 5 MI, 10 strokes, 4 cardiovascular deaths, and 
6 noncardiovascular deaths (2 because of cancer, 4 because of 
other causes). Secondary events occurred in 6 patients; these 
included 2 TIA, 2 strokes, 2 revascularization events, 2 deaths: 
1 because of cancer and 1 of unknown cause. One person had a 
second recurrent TIA after having a stroke followed by the sec-
ondary TIA (thus stroke was the primary event and there were 2 
TIAs afterward). Another patient, after having an MI as the ini-
tial event, died after revascularization from an unknown cause.
Table 2 shows the distribution of events by the 2 cat-
egories of ulcer volume. Figure II in the online-only Data 
Supplement shows the relationship of total plaque area to 
total plaque volume.
 Event-free survival free of stroke, TIA, or death was sig-
nificantly worse in patients with TUV ≥5 mm3 (log-rank 
Figure 2. Distribution of total ulcer volume by ulcer number. The 
number of ulcers ranged from 0 to 4; total ulcer volume ranged 
from 1.01 to 12.35 mm3; total ulcer volume and ulcer number 
overlapped considerably.











  Age, y 69.88±8.65 72.68±10.55 0.18
  Ulcer volume, mm3 0.81±1.25 7.15±2.04 0.0001
  Ulcer number 0.42±0.63 2.42±0.77 0.0001
  Systolic blood pressure, mm Hg 134±20 138±21 0.40
  Diastolic blood pressure, mm Hg 76±13 75±9 0.73
  Total cholesterol, mmol/L 4.12±1.01 4.23±1.35 0.64
  Triglycerides, mmol/L 1.39±0.78 1.39±0.79 0.98
  HDL cholesterol, mmol/L 1.40±0.44 1.43±0.42 0.83
  LDL cholesterol, mmol/L 2.13±0.95 2.22±1.08 0.69
  Homocysteine, μmol/L 9.60±4.11 10.25±4.11 0.76
  Smoking, pack-years 14.82±20.54 17.82±16.03 0.54
  Total plaque area, mm2 166.73±80.97 266.21±125.93 0.0001
  Maximal stenosis, %† 44.81±14.31 45.26±17.11 0.90
Categorical variables, %
  Sex (male) 57.1% 63.2% 0.39
  Diabetic 21.8% 10.5% 0.194
  Still smoking 9.6% 21.1% 0.025
Medication at baseline
  ACE inhibitor 49.3% 52.6% 0.48
  Antiplatelet agent 79.3% 63.2% 0.09
  Statin 85.7% 89.5% 0.48
  Anticoagulant 10.5% 35.6% 0.016
Medication at first follow-up visit
  ACE inhibitor 50.3% 57.9% 0.35
  Antiplatelet agent 79.2% 68.4% 0.20
  Statin 89.9% 94.7% 0.43
  Anticoagulant 10.1% 26.3% 0.046
ACE indicates angiotensin-converting enzyme; HDL, high-density lipoprotein; 
and LDL, low-density lipoprotein.
*ANOVA for continuous variables, exact χ2 for categorical variables.
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P=0.009; Figure 3); for survival free of stroke, TIA, death, MI, 
or revascularization, the log-rank P value was 0.017. In sen-
sitivity analyses, ulcer volumes <5 mm3 did not significantly 
predict events. At a cutoff of 3 mm3, the log-rank P value for 
stroke, TIA, or death was 0.80 (Figure III in the online-only 
Data Supplement).
Maximum ulcer depth ranged from 0.7 to 2.7 mm (mean, 
0.53+0.70 mm). Ulcer depth did not predict events (Figure IV 
in the online-only Data Supplement).
Discussion
In the North American Symptomatic Carotid Endarterectomy 
Trial (NASCET), the presence of angiographically identified 
ulcers was associated with a clinically important increase in 
risk: “The risk of ipsilateral stroke at 24 months for medi-
cally treated patients with ulcerated plaques increased incre-
mentally from 26.3% to 73.2% as the degree of stenosis 
increased from 75% to 95%. For patients with no ulcer, the 
risk of stroke remained constant at 21.3% for all degrees of 
stenosis. The net result yielded relative risks of stroke (ulcer 
versus no ulcer) ranging from 1.24 (95% confidence interval, 
0.61–2.52) to 3.43 (95% confidence interval, 1.49–7.88).”6 
However, angiography was not sensitive or specific for the 
detection of ulceration identified in surgical specimens: 
“Sensitivity and specificity of detecting ulcerated plaques 
were 45.9% and 74.1%, respectively. The positive predictive 
value of identifying an ulcer was 71.8%.”15 Fisher et al16 found 
that histologically validated ulceration was more common in 
endarterectomy specimens from patients with symptomatic 
carotid stenosis versus asymptomatic stenosis. De Bray et al17 
found that the reproducibility of detection of ulceration by 2D 
ultrasound was only 0.41. Schminke et al5 reported that they 
could reliably follow progression or regression of ulceration 
by 3D ultrasound.
Our findings also indicate that the volume of ulceration can 
be measured reliably and that ulcer volume identifies patients 
at risk of cardiovascular events. We found that the volume of 
carotid plaque ulceration measured by 3D carotid ultrasound 
imaging predicted risk of stroke, TIA, or death and the risk of 
stroke/TIA/death/MI/revascularization. These findings are in 
agreement with previously reported studies showing that irreg-
ular and ulcerated plaques were associated with an increased 
risk of stroke.5,8,9 This study is unique in that it assessed the 
volume of ulceration as a predictor of vascular events.
Some readers may be surprised to see an ulcer dimension 
as high as 5 mm3. However, this did not represent ulcer depth. 
Figure 2 shows that among patients with only 1 ulcer, the 
largest ulcer was <8 mm3 (ie, ≈2 mm wide by 2 mm long×2 
mm deep), and most were <4 mm3 (ie, ≈2 mm wide by 2 mm 
long×1 mm deep). As shown in Figure II in the online-only 
Data Supplement, patients with TUV ≥5 mm3 and a mean total 
plaque area of 266 mm2 (2.66 cm2) as shown in Table 1 would 
have total plaque volumes of <400 mm3, so they would have 
ample plaque to accommodate ulcers of that size.
In view of the small size of our study, validation will be 
required by other groups and in larger numbers of patients. It 
would be useful to know whether large ulcers on 1 side predict 
ipsilateral stroke or TIA.
It seems likely that the presence of a large volume ulcer-
ation may be useful in identifying which patients with asymp-
tomatic carotid stenosis and which patients with symptomatic 
stenosis <60% to 70% might benefit from endarterectomy or 
stenting. It is also possible that ulceration might represent a 
therapeutic target in the management of high-risk patients and 
in the evaluation of new therapies for atherosclerosis.
Conclusions
Carotid TUV predicts higher risk of cardiovascular events. In 
addition to identifying high-risk patients who would warrant 
more intensive medical therapy, a high ulcer volume may help 
in identifying which patients with carotid stenosis might ben-
efit from endarterectomy or stenting.
Sources of Funding
The main study was funded by the Heart and Stroke Foundation of 
Canada (Ontario), grant number NA5912. M. Kuk was supported by 
the Canadian Stroke Network Summer Studentship Program and the 
Figure 3. Kaplan–Meier survival analysis curves for participants 
with total ulcer volume (TUV) ≥5.00 mm3 and those with no 
ulcerations or TUV <5 mm3. Time is shown in days until the first 
occurrence of any of the following events: stroke, transient isch-
emic attack (TIA), or cardiovascular death during the duration of 
follow-up; log-rank P=0.009.







Transient ischemic attack 9 (3%) 2 (10.5%)
Stroke 9 (3%) 1 (5.3%)
Myocardial infarction 5 (1.7%) 0
Revascularization 11 (3.6%) 2 (10.5%)
Vascular death 4 (1.3%)  0
Total vascular events 38 (12.5%) 5 (26.3%)
Nonvascular death  5 (1.7%)  1 (5.3%)
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